You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cord Blood Transplant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023

Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)

Completed
Has Results
  • Myeloid Hematological Malignancies
  • Houston, Texas
    Texas Children's Hospital
May 13, 2022

Pediatric Cancer Trial in Manchester (Granulocytes)

Recruiting
  • Pediatric Cancer
  • Granulocytes
  • Manchester, United Kingdom
    Royal Manchester Childrens Hospital, MFT
Jun 17, 2022

Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

Recruiting
  • Leukemia
  • +2 more
  • applying of FLU+CY post-HSCT
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Nov 23, 2023

Congenital Pediatric Disorders Trial in Houston (Busulfan, Cytoxan, Fludarabine)

Active, not recruiting
  • Congenital Pediatric Disorders
  • Houston, Texas
    Texas Children's Hospital
Feb 4, 2022

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))

Recruiting
  • Severe Aplastic Anemia
  • Anti-Thymocyte Globulin (Rabbit)
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Sep 9, 2023

Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States

Recruiting
  • Acute Myelogenous Leukemia (AML)
  • +5 more
  • Conditioning Chemotherapy
  • Cord blood graft
  • Basking Ridge, New Jersey
  • +6 more
May 22, 2023

Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)

Recruiting
  • Hematologic Disorders
  • Miltenyi CliniMACS® CD34 Reagent System
  • Aurora, Colorado
    University of Colorado
Feb 22, 2022

Sickle Cell Disease, Umbilical Cord Blood, Hematopoietic Cell Proliferation Trial in Palo Alto, San Francisco (ECT-001-CB

Withdrawn
  • Sickle Cell Disease
  • +2 more
  • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
  • Palo Alto, California
  • +1 more
Jun 29, 2022

High Risk Hematological Malignancy, Cord Blood Transplant Trial in Seattle (ECT-001-CB (UM171-Expanded Cord Blood Transplant))

Recruiting
  • High Risk Hematological Malignancy
  • Cord Blood Transplant
  • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
  • Seattle, Washington
    Fred Hutchinson / University of Washington Cancer Consortium
Jan 12, 2022

AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

Recruiting
  • AML
  • +8 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 13, 2022

Bone Marrow Transplantation Recipient, Cord Blood Transplant Recipient, Hematopoietic Cell Transplantation Recipient Trial in

Active, not recruiting
  • Bone Marrow Transplantation Recipient
  • +2 more
  • Eltrombopag Olamine
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Multiple Myeloma Trial in Montréal (ECT-001 (UM171) expanded cord blood)

Active, not recruiting
  • Multiple Myeloma
  • ECT-001 (UM171) expanded cord blood
  • Montréal, Quebec, Canada
    CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maiso
Mar 8, 2022

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Seattle

Recruiting
  • Acute Biphenotypic Leukemia
  • +5 more
  • Dilanubicel
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 11, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +18 more
  • Aurora, Colorado
  • +2 more
Dec 28, 2022

Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • +3 more
  • Cord Blood Transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 22, 2021

High Risk Myeloid Malignancies, Cord Blood Transplant Trial in New York (ECT-001-CB (UM171-Expanded Cord Blood Transplant))

Recruiting
  • High Risk Myeloid Malignancies
  • Cord Blood Transplant
  • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 12, 2022

High Risk Hematologic Malignancy, Cord Blood Transplant Trial in Montréal (Transplant with an expanded ECT-001 cord blood)

Recruiting
  • High Risk Hematologic Malignancy
  • Cord Blood Transplant
  • Transplant with an expanded ECT-001 cord blood
  • Montréal, Quebec, Canada
    CIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemo
Aug 2, 2021

Bone Marrow Transplant, Stem Cell Transplant Trial in Aurora (Zoster Vaccine Recombinant)

Not yet recruiting
  • Bone Marrow Transplant
  • Stem Cell Transplant
  • Zoster Vaccine Recombinant
  • Aurora, Colorado
    University of Colorado Hospital
Mar 17, 2023

Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

Active, not recruiting
  • Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Stem Cell Transplantation Trial in Durham (Thymic Transplantation for Recipients of UCB transplant)

Terminated
  • Stem Cell Transplantation
  • Thymic Transplantation for Recipients of UCB transplant
  • Durham, North Carolina
    Duke University Health System
Mar 21, 2022

Hematologic Malignancies Trial in United States (ProHema-CB, Untreated CB)

Terminated
  • Hematologic Malignancies
  • ProHema-CB
  • Untreated CB
  • Duarte, California
  • +10 more
Nov 26, 2021

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in Aurora,

Completed
  • Acute Biphenotypic Leukemia
  • +6 more
  • Aurora, Colorado
  • +2 more
Jan 12, 2022